Exchange: NASDAQ·Updated 07:30 PM EDT
ADPT logo

ADPT Adaptive Biotechnologies Corp

$26.33
$0.40
(1.53%)
Today
Closed $26.49
$0.16
(0.60%)
After Hours
EarningsNov 4
Mkt Cap$4.16B
Vol1.53M

About ADPT

Adaptive Biotechnologies Corp. engages in the development of an immune medicine platform. Its products and services include immunoSEQ, clonoSEQ, cellular therapy, and vaccines. The company was founded by Chad Robins, Harlan Robins, and Chris Carlson on September 8, 2009 and is headquartered in Seattle, WA.
68

Bullish Sentiment

How do you feel about ADPT?

Treasury225
$ADPT no. Some holders should learn how to place a sell order on a small cap stock. Give away your own money and cause confusion. Dammit!

Advertisement|Remove ads.